SE414928B - Forfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepiner - Google Patents

Forfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepiner

Info

Publication number
SE414928B
SE414928B SE7301375A SE137572A SE414928B SE 414928 B SE414928 B SE 414928B SE 7301375 A SE7301375 A SE 7301375A SE 137572 A SE137572 A SE 137572A SE 414928 B SE414928 B SE 414928B
Authority
SE
Sweden
Prior art keywords
benzodiazepines
triazolo
preparing
Prior art date
Application number
SE7301375A
Other languages
English (en)
Swedish (sv)
Inventor
Jr J B Hester
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Priority claimed from US00372313A external-priority patent/US3856792A/en
Publication of SE414928B publication Critical patent/SE414928B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7301375A 1971-02-09 1972-02-07 Forfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepiner SE414928B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11404971A 1971-02-09 1971-02-09
US24075672A 1972-04-03 1972-04-03
US00372313A US3856792A (en) 1971-02-09 1973-06-21 2-{8 2-(substituted aminomethyl)-4h-1,2,4-triazol-4-yl{9 benzophenones

Publications (1)

Publication Number Publication Date
SE414928B true SE414928B (sv) 1980-08-25

Family

ID=27381433

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7301375A SE414928B (sv) 1971-02-09 1972-02-07 Forfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepiner

Country Status (14)

Country Link
US (1) US3709898A (Direct)
JP (1) JPS4966679A (Direct)
BE (1) BE779144A (Direct)
BR (1) BR7200590D0 (Direct)
CA (1) CA966123A (Direct)
CH (2) CH570404A5 (Direct)
DE (2) DE2265617C3 (Direct)
DK (1) DK513578A (Direct)
FR (1) FR2124559B1 (Direct)
GB (4) GB1374823A (Direct)
HK (1) HK2580A (Direct)
NL (1) NL151709B (Direct)
SE (1) SE414928B (Direct)
ZA (1) ZA7251B (Direct)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE397831B (sv) * 1971-06-05 1977-11-21 Takeda Chemical Industries Ltd Sett att framstella s-triazolo-(4,3-a)(1,4)bensodiazepinderivat
US3904641A (en) * 1971-06-18 1975-09-09 Yoshitomi Pharmaceutical Triazolothienodiazepine compounds
BE790838A (fr) * 1971-11-02 1973-04-30 Upjohn Co Nouvelles 1-aminophenyl-6-phenyl-s-triazolo (4,3-a) (1,4)- benzodiazepines, leur procede de preparation et medicament les contenant
US3879413A (en) * 1973-02-14 1975-04-22 Upjohn Co Process for the production of 6-phenyl-4-H-s-triazolo {8 4,3-a{9 {8 1,4{9 benzodiazepines
CA999000A (en) * 1973-02-14 1976-10-26 Jackson B. Hester (Jr.) Process for new benzodiazepines and intermediates
US3842090A (en) * 1973-02-14 1974-10-15 Upjohn Co Certain 1-aminomethyl-6-phenyl 4h-s-triazolo(4,3-a)(1,4)benzodiazepines
US4263310A (en) * 1974-03-02 1981-04-21 Boehringer Ingelheim Gmbh 8-Bromo-6-(o-chloro-phenyl)-4H-S-triazolo-[3,4,-c]-thieno-[2,3-e]-1,4-diazepines and salts thereof
GB1517164A (en) * 1974-08-20 1978-07-12 Roche Products Ltd Substituted-phenyl ketones and a process for the manufacture thereof
US4000151A (en) * 1974-09-11 1976-12-28 The Upjohn Company Triazolyl benzophenone compounds
US4000153A (en) * 1974-09-26 1976-12-28 The Upjohn Company Triazolobenzodiazepine intermediates
CA1060892A (en) * 1974-11-06 1979-08-21 Parke, Davis And Company Diazepine compounds and method for their production
CH601267A5 (Direct) * 1975-12-12 1978-06-30 Ciba Geigy Ag
US4075408A (en) * 1975-09-08 1978-02-21 Parke, Davis & Company Imidazopyrazolodiazepine compounds
US4009175A (en) * 1976-03-15 1977-02-22 The Upjohn Company 1-[(Aminooxy)-methyl]-6-substituted-4H-s-triazolo[4,3-a][1,4] benzodiazepines
US4405518A (en) * 1981-07-23 1983-09-20 Hoffmann-La Roche Inc. Pyrrolo[3,4-d] [2] benzazepines
US4409390A (en) * 1981-07-23 1983-10-11 Hoffmann-La Roche Inc. Pyrrolo[3,4-D][2]Benzazepines
US4375473A (en) * 1982-01-04 1983-03-01 The Upjohn Company Method
US4501698A (en) * 1983-03-31 1985-02-26 The Upjohn Company Preparing 1-(hydroxymethyl)-triazolobenzodiazepines and 1-(aminomethyl)-triazolobenzodiazepines
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
EP2571875A4 (en) 2010-05-14 2013-10-30 Dana Farber Cancer Inst Inc CONTRACEPTIVE COMPOSITIONS FOR MEN AND METHODS OF USE THEREOF
BR112012029005A2 (pt) 2010-05-14 2016-07-26 Dana Farber Cancer Inst Inc composições e métodos de tratamento de neoplasia, doença inflamatória e outros distúrbios
EP2569434B1 (en) 2010-05-14 2019-09-04 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating leukemia and related disorders
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2721031B1 (en) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2864336B1 (en) 2012-06-06 2016-11-23 Constellation Pharmaceuticals, Inc. Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
US9975896B2 (en) 2013-07-25 2018-05-22 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
WO2015070020A2 (en) 2013-11-08 2015-05-14 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
KR20160115953A (ko) 2014-01-31 2016-10-06 다나-파버 캔서 인스티튜트 인크. 디아미노피리미딘 벤젠술폰 유도체 및 그의 용도
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
KR20160130778A (ko) 2014-02-28 2016-11-14 텐샤 세러퓨틱스 인코포레이티드 고인슐린혈증과 관련된 질환의 치료
SI3157928T1 (sl) 2014-06-20 2019-06-28 Constellation Pharmaceuticals, Inc. Kristalinične oblike 2-((4S)-6-(4-klorofenil)-1-metil-4H-benzo(C)izoksazolo(4,5-E)azepin-4-il acetamida
CA2955074A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
CN106793775B (zh) 2014-08-08 2020-06-02 达纳-法伯癌症研究所股份有限公司 二氢碟啶酮衍生物及其用途
CR20170219A (es) 2014-10-27 2017-08-14 Tensha Therapeutics Inc Inhibidores del bromodominio
CA2986441A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
MX2018003031A (es) 2015-09-11 2018-08-01 Dana Farber Cancer Inst Inc Ciano tienotriazolpirazinas y usos de las mismas.
RU2018112953A (ru) 2015-09-11 2019-10-14 Дана-Фарбер Кэнсер Инститьют, Инк. Ацетамидтиенотриазолодиазепины и пути их применения
CA3003288A1 (en) 2015-11-25 2017-06-01 Dana-Farber Cancer Institute, Inc. Bivalent bromodomain inhibitors and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413346A (en) * 1966-01-19 1968-11-26 Hoffmann La Roche 2-(2-haloethylamino)-5-halo-benzophenones
US3987052A (en) * 1969-03-17 1976-10-19 The Upjohn Company 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
DE1955349C2 (de) * 1969-11-04 1982-01-28 Takeda Chemical Industries, Ltd., Osaka s-Triazolo [4,3-a] [1,4] benzodiazepine
YU34997B (en) * 1970-03-27 1980-06-30 Hiroyuki Tawada Process for preparing benzodiazepine derivatives

Also Published As

Publication number Publication date
JPS4966679A (Direct) 1974-06-27
DK513578A (da) 1978-11-17
DE2203782C2 (de) 1982-05-13
CA966123A (en) 1975-04-15
AU3772572A (en) 1973-07-12
CH570404A5 (Direct) 1975-12-15
DE2203782A1 (de) 1972-08-24
DE2265617C3 (de) 1982-05-06
DE2265617B2 (de) 1981-07-16
BE779144A (fr) 1972-08-09
NL7201692A (Direct) 1972-08-11
FR2124559A1 (Direct) 1972-09-22
BR7200590D0 (pt) 1973-07-17
GB1374824A (en) 1974-11-20
CH569736A5 (Direct) 1975-11-28
GB1374822A (en) 1974-11-20
GB1374823A (en) 1974-11-20
NL151709B (nl) 1976-12-15
US3709898A (en) 1973-01-09
HK2580A (en) 1980-01-25
FR2124559B1 (Direct) 1975-08-01
GB1374825A (en) 1974-11-20
ZA7251B (en) 1972-09-27

Similar Documents

Publication Publication Date Title
SE414928B (sv) Forfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepiner
SE387641B (sv) Analogiforfarande for framstellning av s-triaxolo(4,3-a)(1,4)bensodiazepiner
SE402592B (sv) Forfarande for framstellning av 2-alkyl-3-acyl-pyrazolo(1,5-a)pyridiner
GB1403866A (en) Derivatives of 3-amino-1,2,4-triazoles
SE425785B (sv) Analogiforfarande for framstellning av imidazo (1,5-a)(1,4) diazzepinderivat
SE410605B (sv) Forfarande for framstellning av pyrazolo(3,4-e)(1,4)diazepinforeningar
SE419865B (sv) Analogiforfarande for framstellning av s-triazolo /4,3-a/kinazolinderivat
SE399895B (sv) Forfarande for framstellning av s-triazolo(3,4-b)benstiazoler
BG24409A3 (en) Method of preparing derivatives of s-triazole(4,3-a) quinoline
SE419989B (sv) Analogiforfarande for framstellning av s-triozolo (4,3-a)(1,5) bensodiazepiner
BG22824A3 (bg) Метод за получаване на бензодиазепинови производни
SE380804B (sv) Anologiforfarande for framstellning av s-triazolo (1,5-a) (1,4)
SE397832B (sv) Analogiforfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepinderivat
SE399709B (sv) Sett att framstella pyrimido(1,2-a)(1,4)bensodiazepiner
SE423901B (sv) Analogiforfarande for framstellning av indolo /2,3-a/ kinoliziner
SE415475B (sv) Forfarande for framstellning av 4,5-didehydro-pgf?711alfa
PH10943A (en) An improved process for the manufacture of benzodiazepine derivatives
SE397831B (sv) Sett att framstella s-triazolo-(4,3-a)(1,4)bensodiazepinderivat
SE415101B (sv) Analogiforfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepinderivat
SE387347B (sv) Analogiforfarande for framstellning av s-triazolo (4,3-a) (1,4) bensodiazepinderivat
SE407685B (sv) Analogiflrfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepinderivat
SE413408B (sv) Analogiforfarande for framstellning av derivat av s-triozolo(4,3-a)-(1,4)bensodiazepiner
SE414498B (sv) Analogiforfarande for framstellning av kondenserade s-triazolo-(1,5-a)(1,4)bensodiazepinderivat
FI52728C (fi) Menetelmä s-triatsolo(4,3-a)(1,4)bentsosiatsepiinijohdannaisten valmis tamiseksi.
SE415102B (sv) Analogiforfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepinderivat